Substrate-selective COX-2 inhibition as a novel strategy for therapeutic endocannabinoid augmentation
Year: 2014
Type: review
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: G1576192539, Research Center for Pharmacology and Drug Toxicology, Functional Analysis of Cyclooxygenase-2, Substrate-selective inhibition of COX-2 to target affective disorders, Research Center for Pharmacology & Drug Toxicology, Initiative for Maximizing Student Development, Oxidative Metabolites of Curcumin and their Biological Activity, Stress adaptations in endocannabinoid signaling in the amygdala, (R)-flurbiprofen Substrate-Selective Inhibition of COX-2 and Analog Development
OpenAlex ID: W2049351028
